Premium Nahrungsergänzungsmittel | artgerecht

FIB-4 Index: Meaning, Calculation & Interpretation

The FIB-4 index is a simple blood test used to assess liver scarring. It combines age, liver enzyme levels, and platelet count into a single score.

Regular tips about health Regular tips about health

Things worth knowing about "Fibrosis index FIB-4"

The FIB-4 index is a simple blood test used to assess liver scarring. It combines age, liver enzyme levels, and platelet count into a single score.

What is the FIB-4 Index?

The FIB-4 index (Fibrosis-4 index) is a non-invasive laboratory score used to assess the likelihood of liver fibrosis – the formation of scar tissue in the liver. Originally developed for patients with chronic hepatitis C, the FIB-4 index is now widely used across various liver conditions, including non-alcoholic fatty liver disease (NAFLD/MASLD) and alcoholic liver disease.

A major advantage of the FIB-4 index is that it relies entirely on routine blood test results, meaning no additional invasive procedures are required for its calculation.

How is the FIB-4 Index Calculated?

The FIB-4 score is calculated using the following formula:

FIB-4 = (Age [years] × AST [U/L]) ÷ (Platelets [10&sup9;/L] × √ALT [U/L])

The formula uses four variables:

Age of the patient in years
AST (aspartate aminotransferase): a liver enzyme measured in the blood
ALT (alanine aminotransferase): another liver enzyme measured in the blood
Platelets (thrombocytes): blood cell count involved in clotting

Interpreting the Results

FIB-4 scores are generally interpreted in three categories:

FIB-4 < 1.30: Low probability of advanced liver fibrosis (fibrosis stage F0–F1)
FIB-4 between 1.30 and 2.67: Indeterminate zone – further evaluation is recommended
FIB-4 > 2.67: High probability of advanced liver fibrosis (fibrosis stage F3–F4)

Exact cut-off values may vary slightly depending on the clinical guideline and context used. In patients over 65 years of age, the FIB-4 index should be interpreted with caution, as older patients may have higher scores independent of advanced fibrosis due to the age component in the formula.

Clinical Use

The FIB-4 index is typically applied in the following clinical situations:

Initial screening when chronic liver disease is suspected
Monitoring disease progression in patients with fatty liver disease (NAFLD/MASLD)
Risk stratification in patients with chronic hepatitis B or C
Guiding decisions about whether a liver biopsy or advanced imaging is necessary

Advantages and Limitations

The FIB-4 index offers several advantages:

No additional costs, as it uses standard laboratory values
Non-invasive and therefore risk-free for the patient
Strong ability to rule out advanced fibrosis (high negative predictive value)

However, important limitations also exist:

Reduced accuracy in the intermediate score range
Results can be influenced by age-related changes, muscle mass, and comorbidities
Not a substitute for liver biopsy in cases with unclear results

References

Sterling RK et al. - Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 2006; 43(6):1317–1325.
European Association for the Study of the Liver (EASL) - EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology, 2021; 75(3):659–689.
Angulo P et al. - Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology, 2013; 145(4):782–789.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.